Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Disease (ASCVD)”

92 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 92 results

Large-scale testing (Phase 3)Looking for participantsNCT06813911
What this trial is testing

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)
Novartis Pharmaceuticals 340
Large-scale testing (Phase 3)Looking for participantsNCT07000357
What this trial is testing

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 15,100
Not applicableLooking for participantsNCT06406998
What this trial is testing

Maternal and Offspring Outcomes in Pregnant Women With Pre-existing ASCVD

Who this might be right for
Cardiovascular DiseasesAtherosclerosisPregnancy Complications+2 more
Samsung Medical Center 5,461,222
Post-approval studies (Phase 4)Study completedNCT03597412
What this trial is testing

Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM

Who this might be right for
Atherosclerotic Cardiovascular DiseaseType 2 Diabetes Mellitus
Yuhan Corporation 236
Large-scale testing (Phase 3)Study completedNCT06005597
What this trial is testing

Study of Obicetrapib & Ezetimibe Fixed Dose Combination on Top of Maximum Tolerated Lipid-Modifying Therapies

Who this might be right for
DyslipidemiasHypercholesterolemiaFamilial Hypercholesterolemia+2 more
NewAmsterdam Pharma 407
Not applicableLooking for participantsNCT05879913
What this trial is testing

ASCVD Management Using CCTA in Prostate Cancer Patients on ADT

Who this might be right for
Prostate Cancer
Indiana University 100
Large-scale testing (Phase 3)Study completedNCT04807400
What this trial is testing

Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support

Who this might be right for
Atherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease Risk EquivelentsElevated Low Density Lipoprotein Cholesterol
Novartis Pharmaceuticals 892
Large-scale testing (Phase 3)Looking for participantsNCT06930885
What this trial is testing

Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease

Who this might be right for
Atherothrombotic DiseasesAtherosclerotic Cardiovascular Disease (ASCVD)
Hospital do Coracao 7,713
Not applicableUnknownNCT03868332
What this trial is testing

Predictors of Subclinical Atherosclerotic Cardiovascular Diseases (ASCVD) in Patients With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Diseases
Assiut University 80
Large-scale testing (Phase 3)Looking for participantsNCT05485961
What this trial is testing

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

Who this might be right for
Atherosclerotic Cardiovascular DiseaseEnd Stage Kidney DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring 2,310
Not applicableLooking for participantsNCT07334834
What this trial is testing

Implementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular Disease

Who this might be right for
Hyperlipidemia
Colorado Prevention Center 100
Post-approval studies (Phase 4)UnknownNCT03403556
What this trial is testing

High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes

Who this might be right for
Atherosclerotic Cardiovascular DiseaseType 2 Diabetes
Yuhan Corporation 140
Post-approval studies (Phase 4)Study completedNCT03474562
What this trial is testing

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Who this might be right for
ASCVDImpaired Fasting GlucoseHypertension
Yuhan Corporation 100
Large-scale testing (Phase 3)Active Not RecruitingNCT07000123
What this trial is testing

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event

Who this might be right for
Cardiovascular Disease
AstraZeneca 3,046
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07311330
What this trial is testing

Phase IIa Clinical Trial of YN001 in Patients With Atherosclerotic Cardiovascular and Cerebrovascular Diseases and Erectile Dysfunction

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Erectile Dysfunction
Beijing Inno Medicine Co., Ltd. 40
Not applicableActive Not RecruitingNCT07417618
What this trial is testing

INcreTin-based thERapies for Cardiovascular Event PrevenTion in Patients With and Without ASCVD (INTERCEPT-ASCVD)

Who this might be right for
Type 2 DiabetesOverweightASCVD
Brigham and Women's Hospital 60,000
Not applicableNot Yet RecruitingNCT07355894
What this trial is testing

Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Coronary Artery Calcification
Stanford University 120,000
Large-scale testing (Phase 3)Study completedNCT02991118
What this trial is testing

Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease
Esperion Therapeutics, Inc. 779
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableStudy completedNCT07196280
What this trial is testing

Protective Effect of 5-Alpha Reductase Inhibitors on Atherosclerotic Cardiovascular Disease in Populations With BPH: Evidence From UK Biobank Cohort and Chinese Single Center Database Studies

Who this might be right for
Atherosclerotic Cardiovascular Disease (ASCVD)Benign Prostatic Hypertrophy (BPH)
Chinese PLA General Hospital 10,000
Load More Results